Gelteq Limited (GELS)
| Market Cap | 4.99M -81.6% |
| Revenue (ttm) | 270,853 +188.3% |
| Net Income | -4.36M |
| EPS | -0.47 |
| Shares Out | 10.71M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 47,921 |
| Open | 0.4633 |
| Previous Close | 0.4455 |
| Day's Range | 0.4472 - 0.5127 |
| 52-Week Range | 0.4388 - 3.5100 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 22, 2026 |
About GELS
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Financial Performance
In fiscal year 2025, Gelteq's revenue was 413,132, an increase of 188.27% compared to the previous year's 143,313. Losses were -6.65 million, 87.4% more than in 2024.
Financial numbers in AUD Financial StatementsNews
Healthy Extracts Reports 2025 Net Revenue Up 45% to Record $4.5 Million
2025 Non-GAAP Net Income Totaled $162,000 or $0.02 Per Share Record Results Driven by Fifth Sequential Quarter of Record-Setting Revenues, with the Momentum Setting Stage for Another Year of Double-Di...
Healthy Extracts Reports Preliminary 2025 Results, Net Revenue Expected Up 45% to Record $4.5 Million
Strong Annual Results Driven by Record-Setting Revenues for Fifth Quarter in a Row, Setting Stage for Another Record Year in 2026 LAS VEGAS, NV / ACCESS Newswire / April 2, 2026 / Healthy Extracts I...
Gelteq, Healthy Extracts enter MOU for manufacturing, commercial partnership
Gelteq (GELS) and Healthy Extracts announced the signing of a Memorandum of Understanding formalising a strategic partnership designed to accelerate the commercial rollout of next-generation gel-based...
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership
MELBOURNE, Australia and LAS VEGAS, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq”) and Healthy Extracts™ Inc. (“Healthy Extracts”) today announced the signing of a Memorandum of Understan...
Gelteq announces preclinical results on medicinal cannabinoid absorption
Gelteq (GELS) announced positive results from a recently completed preclinical study which evaluated medicinal cannabinoids delivery through the Company’s proprietary oral gel platform. The findings d...
Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform
MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of advanced gel-based oral delivery systems, today announced ...
Gelteq announces new partnership with Hong Kong Flag Football Program
Gelteq (GELS) announced a new partnership with the Hong Kong Flag Football Program. The partnership will integrate Gelteq’s advanced hydration and sports performance formulations into the training and...
Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program
Collaboration Combines Growing International Interest in Gelteq's Sports Science Technology with Rising Interest in Flag Football Ahead of 2028 Summer Olympic Games Debut in Los Angeles Collaboration ...
Gelteq entered into three year sales agreement with Mana Health
Gelteq (GELS) announced that it has entered into a three year sales agreement with Shenzhen Mana Health Management under which Mana will distribute consumer nutritional products within China using Gel...
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq's Nutritional Product Expansion into China
Agreement includes minimum annual order commitments totalling approximately USD $1.3 million Agreement includes minimum annual order commitments totalling approximately USD $1.3 million
Gelteq announces preclinical findings from study of gel-based platform
Gelteq (GELS) announced preclinical findings demonstrating the effectiveness, flexibility, and safety profile of its proprietary gel platform. The results address a major challenge in pharmaceutical d...
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform
MELBOURNE, Australia, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of advanced gel-based oral delivery systems, today announced ...
Gelteq to Present at Investor Summit Virtual on December 9, 2025
MELBOURNE, Australia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (Nasdaq: GELS) (“Gelteq”) today announced that Nathan Givoni, its Chief Executive Officer, will present at the Q4 Investor Summit...
Gelteq announces ‘positive’ preclinical results for its gel formulation
The company states: “Gelteq (GELS) Limited announced positive preclinical results showing its proprietary gel formulation achieved substantially higher bioavailability than a leading on-market referen...
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
Findings Anticipated to Unlock Broad New Commercial Opportunities Across Water-Soluble Drug Classes Findings Anticipated to Unlock Broad New Commercial Opportunities Across Water-Soluble Drug Classes
Healthy Extracts Reports Record Q3 2025, with Revenue up 23%
LAS VEGAS, NV / ACCESS Newswire / November 14, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in plant-based nutraceutical innovations, reported results for the third quarter and nine months ende...
Nutraceutical Technology Leader, Healthy Extracts, Invited to Present at the Trickle Research Microcap Conference on November 13, 2025
LAS VEGAS, NV / ACCESS Newswire / November 11, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in science-based nutraceuticals and oral delivery technology for transformational health and longevit...
Gelteq announces commencement of preclinical trial for poorly soluble drugs
Gelteq (GELS) announced it has started a preclinical animal trial evaluating its proprietary formulation technology for oily and poorly soluble drugs. Gelteq will conduct the study with Monash Univers...
Gelteq enters Product Development, Profit Share Agreement with Melbourne Health
Gelteq (GELS) announced it has entered into a Product Development and Profit Share Agreement, with Melbourne Health, operator of The Royal Melbourne Hospital and one of Australia’s top public health
Gelteq powers U.S. product launches of Healthy Extracts
Gelteq (GELS) announces recent product launches of Healthy Extracts, whose products apply Gelteq’s proprietary gel technology, into the U.S. nutraceutical market. The Healthy Extracts products are the...
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner
MELBOURNE, Australia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company,” NASDAQ: GELS), a clinical and science-based developer of gel-based oral delivery solutions, welcomes...
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market
MELBOURNE, Australia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, today annou...
Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs
Hydrate EZ™ delivers rapid hydration and essential electrolytes for staying refreshed, sharp and in control. Mynus Sugar™ is clinically formulated to support healthy carbohydrate metabolism.
Healthy Extracts Reports Record Q2 2025 Net Revenue, Driving Positive EPS and EBITDA; Increases 2025 Net Revenue Guidance by 50%
Net Revenue Outlook for 2025 Increased from $4.2 Million+ to $6.3 Million+, Representing Growth of 102%+, Based on Recent Transformative Merger with Gummy USA LAS VEGAS, NV / ACCESS Newswire / August ...
Healthy Extracts Expects Record Sales for Q2 2025, Driving Strong Positive Adj. EBITDA
Q2 2025 adjusted EBIDTA at nearly $100,000, demonstrating strong leverage in the company's marketing and distribution channel platform. Subscription-based recurring revenue continues to drive strong p...